Mark Mcdade - Director at Tourmaline Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TRML on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Mcdade since 12/2/2024

Holdings reported by Mark Mcdade for Tourmaline Bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $47.83 Oct 28, 2025 By Qiming U.S. Healthcare Fund III,L.P.
Common Stock 0 $0 $47.83 Oct 28, 2025 By Qiming U.S. Healthcare Fund II,L.P.
Common Stock 0 $0 $47.83 Oct 28, 2025 By Qiming U.S. Healthcare Fund I,L.P.
Common Stock 0 $0 $47.83 Oct 28, 2025 Direct
Stock Option (Right to Buy) 16.8K Jun 4, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 0 Oct 28, 2025 Direct Common Stock

Transactions reported by Mark Mcdade for Tourmaline Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.